Welcome to our dedicated page for Arkema news (Ticker: ARKAY), a resource for investors and traders seeking the latest updates and insights on Arkema stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Arkema's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Arkema's position in the market.
Arkema has announced plans to double the capacity of its polyester resins at its Navi Mumbai facility in India. This significant investment demonstrates Arkema's commitment to the powder coatings market and development of low-VOC technologies. The company aims to support increased demand from the automotive, household, and industrial sectors. Arkema reported approximately €9.5 billion in sales in 2021 and aims to position itself as a pure player in Specialty Materials by 2024.
Arkema has been recognized among the top companies in the chemicals sector, ranking third in the DJSI World for 2022 and second in the DJSI Europe.
The company's sustainability score improved to 83 out of 100 in the Standard & Poor's Corporate Sustainability Assessment. Key achievements include effective management of product and water risks and a commitment to reduce greenhouse gas emissions by 46% by 2030. Arkema aims to become a pure player in Specialty Materials by 2024, with a goal to address various sustainable material demands.
Arkema, listed on Euronext Paris under the symbol AKE, has reported its total share information as of November 30, 2022. The total number of shares amounts to 75,043,514. The total voting rights, including shares held by the company, are 91,664,041, while the voting rights excluding shares held by the company stand at 91,475,899.
Arkema has announced share buyback transactions from November 14 to November 18, 2022. During this period, a total of 1,778 shares were repurchased at a weighted average price of €85.00 per share. This action aligns with the company's strategy to optimize capital allocation and enhance shareholder value. Detailed information regarding the share buybacks is available on Arkema's website.
Arkema, listed on Euronext Paris as AKE, reported share buyback transactions conducted between November 7 and November 11, 2022. A total of 20,222 shares were repurchased at a weighted average price of 83.98 per share. The transactions were part of the company's strategy to return value to shareholders and comply with EU regulations. The details include daily volumes ranging from 778 to 7,000 shares, with prices varying slightly across the transaction dates.
Arkema reported strong financial results for Q3 2022, with sales up 23.9% year-over-year to €2.972 billion, driven by demand for high-value materials. EBITDA increased by 4.4% to €495 million, maintaining an EBITDA margin of 16.7%. Specialty Materials performed well with an 8.3% EBITDA rise, while Intermediates saw an 18.1% decline. The company confirmed its EBITDA target of €2.1 billion for 2022, despite challenges in Europe and inflation. Cash flow surged to €434 million, and net debt decreased to €2.615 billion. Arkema is focused on sustainable innovations and cost management strategies.
From October 31 to November 4, 2022, Arkema (Euronext Paris: AKE) conducted a total of 28,000 shares buyback transactions at a weighted average price of 81.1295 per share. The company executed these transactions in compliance with Article 5 §2 of Regulation (EU) No 596/2014. The share repurchase is aimed at enhancing shareholder value.
Details of the transactions confirm the systematic repurchase of shares over the specified dates, reflecting the company's commitment to returning capital to shareholders.
Arkema reported the total number of shares and voting rights as of October 31, 2022, with a total of 75,043,514 shares outstanding. The total number of voting rights, including shares held by the company, is 89,572,505. Excluding shares held by the company, the total voting rights stand at 89,343,905. This disclosure reflects the company's commitment to transparency in shareholder communications.
Arkema has announced the proposed divestment of Febex, a company specializing in phosphorus-based chemistry, to Belgian group Prayon. This move reflects Arkema's ongoing efforts in business portfolio management. Febex, which reported sales of approximately €30 million in 2021 and operates one site in Switzerland, will benefit from Prayon's growth ambitions. The transaction is subject to employee consultations in France and approval by Swiss authorities, with completion expected in Q1 2023. This divestment aligns with Arkema's strategy to focus on Specialty Materials, which accounted for 85.5% of its 2021 sales.
Arkema has successfully completed its 8th capital increase reserved for employees, raising approximately €49 million. A total of 7,400 employees and former employees subscribed for 757,473 shares, reflecting strong confidence in the company's future. Participation rates reached 55% in France and 23% internationally. The shares were priced at €64.35, reflecting a 25% discount. Following this increase, employee ownership now accounts for about 7% of the company. Arkema aims to become a leader in Specialty Materials by 2024, positioned in innovative segments that drive sustainable growth.